CD274 and neoplasm: Recent immunotherapy treatments called immune checkpoint inhibitors, like anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, have shown great results in fighting several cancers, by reactivating and rejuvenating worn-out T cells and boosting the anti-tumor immunity to fight tumors [18,19].